Aging Population
The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
Trend Stats
1-Month Return
+4.59%
3-Month Return
+4.42%
12-Month Return
+12.33%
Volatility Score
1.6
RSI
59.9
ST Trend
Up
LT Trend
Up
Short-Term Trend
Up
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Aging Population
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $1.1T | +48.21% | +35.54% | +7.05% | 3.3 | Up | Up |
| JNJ | Johnson&Johnson | $635B | +60.42% | +16.45% | +9.29% | 2.5 | Up | Up |
| ABBV | AbbVie | $458B | +40.53% | +31.45% | +11.20% | 2.5 | Up | Up |
| MRK | Merck | $324B | +59.90% | +17.97% | +8.68% | 2.7 | Up | Up |
| AZN | ASTRAZENECA | $263B | +18.50% | -10.80% | -7.52% | 3.2 | Down | Down |
| AMGN | Amgen | $203B | +26.34% | +9.96% | +7.00% | 2.3 | Up | Up |
| WELL | Welltower REIT | $178B | +58.42% | +21.16% | +13.84% | 2.0 | Up | Up |
| BMY | Bristol-MyersSqu | $127B | +34.36% | +6.95% | +14.17% | 2.6 | Up | Up |
| SYK | Stryker | $127B | -17.33% | +1.11% | +5.56% | 3.4 | Up | Down |
| MDT | Medtronic | $107B | -7.56% | +0.77% | +4.78% | 2.8 | Up | Down |
| REGN | Regeneron Pharma | $69B | +17.14% | -12.58% | +5.23% | 2.5 | Neutral | Down |
| BSX | Boston Scientifi | $66B | -58.31% | -28.71% | -0.47% | 3.2 | Down | Down |
| VTR | Ventas REIT | $49B | +55.14% | +20.93% | +16.81% | 2.0 | Up | Up |
| EW | Edwards Lifescns | $48B | +3.29% | -1.81% | -7.84% | 3.0 | Down | Down |
| ONC | BeOne Medi Sp ADR | $34B | +11.81% | +8.34% | +17.60% | 3.0 | Up | Up |
| DXCM | Dexcom | $28B | -19.61% | +16.19% | +2.57% | 3.7 | Down | Up |
| UTHR | United Therapeut | $26B | +73.55% | -6.82% | -3.90% | 2.6 | Down | Up |
| INCY | Incyte | $24B | +67.62% | +24.32% | +8.49% | 2.9 | Up | Up |
| NBIX | Neurocrine Biosc | $18B | +33.02% | +37.66% | +5.85% | 2.8 | Up | Up |
| ZBH | Zimmer Biomet Hldgs | $18B | -5.37% | +0.36% | +1.14% | 3.5 | Up | Neutral |
| OHI | Omega Hlth REIT | $15B | +40.74% | +13.05% | +9.16% | 1.7 | Up | Up |
| DVA | DaVita | $15B | +62.18% | +55.05% | +10.51% | 2.8 | Up | Up |
| EXEL | Exelixis | $14B | +21.43% | +23.21% | +4.73% | 2.7 | Up | Up |
| PODD | Insulet | $11B | -43.75% | -13.87% | +9.66% | 3.8 | Up | Down |
| ENSG | Ensign Group | $10B | +15.45% | -8.51% | +5.48% | 2.7 | Up | Down |
| HALO | Halozyme Therape | $9.7B | +40.68% | +25.35% | +15.15% | 3.2 | Up | Up |
| GKOS | Glaukos | $9B | +62.86% | +26.42% | +11.48% | 3.7 | Up | Up |
| CGON | CG ONCOLOGY | $6.1B | +165.59% | +0.93% | +0.87% | 5.6 | Up | Up |
| TFX | Teleflex | $5.8B | +14.01% | -3.02% | +4.42% | 3.2 | Neutral | Up |
| SBRA | Sabra HC REIT | $5.6B | +30.54% | +12.90% | +17.13% | 2.4 | Up | Up |
| MMSI | Merit Med Sys | $4.4B | -12.24% | +8.37% | +7.40% | 2.8 | Up | Down |
| LIVN | LivaNova | $4.3B | +79.05% | +21.79% | -2.20% | 2.9 | Neutral | Up |
| ACAD | Acadia Pharma | $4.3B | +6.84% | +13.11% | +6.34% | 3.7 | Up | Up |
| NHI | Natl Health REIT | $3.9B | +18.71% | +5.85% | +8.37% | 2.2 | Up | Up |
| BKD | Brookdale Sr Liv | $3.6B | +101.73% | +9.15% | +3.13% | 4.3 | Up | Up |
| NHC | National Healthc | $3.5B | +138.15% | +30.99% | +11.64% | 3.3 | Up | Up |
| ITGR | Integer Holdings | $3.3B | -9.11% | +14.65% | +7.92% | 2.9 | Up | Up |
| AGIO | Agios Pharm | $2.2B | -9.10% | +43.60% | +0.22% | 5.1 | Up | Up |
| LTC | LTC Prop REIT | $2.2B | +26.50% | +11.93% | +11.30% | 1.8 | Up | Up |
| NVCR | NovoCure NPV | $2B | +46.59% | +41.54% | +19.90% | 6.6 | Up | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |